Histamine-Releasing Factor Oligomers in Food Allergy

食物过敏中的组胺释放因子低聚物

基本信息

  • 批准号:
    10462489
  • 负责人:
  • 金额:
    $ 63.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The prevalence of food allergy has been dramatically increasing for the last few decades. Although studies using murine models of food allergy have greatly advanced our understanding of its pathogenesis, there are still significant knowledge gaps. Histamine-releasing factor (HRF) activate mast cells and basophils in an IgE- dependent manner. As its secretion was found in body fluids during late-phase allergic reactions, HRF has been implicated in allergic diseases. However, whether HRF is involved in allergic diseases had remained enigmatic, although its molecular identity was revealed in 1995. Our 2012 study changed this situation by identifying a subset of IgE and IgG molecules as HRF receptors: mapping of the immunoglobulin (Ig) Fab- binding sites within the HRF molecule led to the discovery of HRF sequence-based inhibitors, N19 and H3 peptides, as well as a monomeric mutant HRF-2CA, all of which blocked HRF-Ig interactions; prophylactic administration of these inhibitors, which targeted mast cells, strongly reduced the incidence of allergic diarrhea and anaphylaxis, as well as the severity of intestinal inflammation in an IgE/FcεRI (high-affinity IgE receptor)/mast cell-dependent mouse model of food allergy. HRF is present as a monomer and disulfide-linked oligomers including a dimer. HRF dimer, but not monomer, has an ability to activate IgE-primed mast cells and basophils and to enhance allergen-triggered activation of these cells. HRF oligomers increased in the small intestine of food allergic animals. Our results collectively suggest that HRF oligomers crosslink IgE-bound FcεRI on intestinal mast cells, leading to their activation, which is required for allergen-induced maximal intestinal type 2 inflammation. Based upon these novel data, we hypothesize that HRF oligomerization and HRF-IgE interactions are two critical events to initiate and amplify intestinal inflammation in food allergy. To test this hypothesis, we will conduct food allergy experiments with novel mutant mice lacking normal HRF dimer (Aim 1), and seek to identify the enzyme system that catalyzes oligomerization of HRF (Aim 2). We will also investigate the effects of HRF oligomerization and N-glycosylation of HRF and IgEs on HRF-IgE interactions, and potential regulation of HRF-IgE interactions at the atomic level during food allergy (Aim 3). Therefore, this study will likely establish a novel paradigm that FcεRI-mediated mast cell activation triggered by antigen is amplified by HRF oligomers that cause a heightened inflammation in food allergy.
项目摘要 在过去的几十年里,食物过敏的患病率急剧增加。尽管研究 使用食物过敏的小鼠模型已经极大地推进了我们对其发病机制的理解, 仍然存在巨大的知识差距。组胺释放因子(HRF)激活IgE-1受体中的肥大细胞和嗜碱性粒细胞。 依赖的方式。由于在后期过敏反应期间在体液中发现HRF分泌物, 与过敏性疾病有关然而,HRF是否参与过敏性疾病的发生, 尽管它的分子身份在1995年被发现,但它仍然是一个谜。我们2012年的研究改变了这种情况, 鉴定IgE和IgG分子的子集为HRF受体:免疫球蛋白(IG)Fab- HRF分子内的结合位点导致了基于HRF序列的抑制剂N19和H3的发现 肽,以及单体突变体HRF-2CA,所有这些都阻断HRF-Ig相互作用;预防性 给予这些针对肥大细胞的抑制剂,大大降低了过敏性腹泻的发生率 和过敏反应,以及IgE/FcεRI(高亲和力IgE)中肠道炎症的严重程度 受体)/肥大细胞依赖性食物过敏小鼠模型。HRF以单体形式存在, 低聚物,包括二聚体。HRF二聚体,而不是单体,具有激活IgE致敏的肥大细胞的能力, 嗜碱性粒细胞,并增强这些细胞的过敏原触发的激活。HRF寡聚体增加,在小 食物过敏动物的肠道。我们的研究结果共同表明,HRF寡聚体交联IgE结合 FcεRI作用于肠肥大细胞,导致其活化,这是过敏原诱导的最大免疫应答所必需的。 肠道2型炎症。基于这些新的数据,我们假设HRF寡聚化和 HRF-IgE相互作用是食物过敏中启动和放大肠道炎症的两个关键事件。到 为了验证这一假设,我们将用缺乏正常HRF的新型突变小鼠进行食物过敏实验 二聚体(目的1),并寻求确定酶系统,催化低聚化的HRF(目的2)。我们将 并研究了HRF寡聚化和HRF和IgE的N-糖基化对HRF-IgE的影响 相互作用,以及食物过敏期间原子水平上HRF-IgE相互作用的潜在调节(目的3)。 因此,本研究将可能建立一种新的范式,即Fcε RI介导的肥大细胞活化由 抗原被HRF寡聚体放大,导致食物过敏中的炎症加剧。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Editorial overview: Recent advances in research of IgE-mediated and IgE-independent allergies, an overview.
编辑概述:IgE 介导和 IgE 非依赖性过敏研究的最新进展,概述。
  • DOI:
    10.1016/j.coi.2021.10.003
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    7
  • 作者:
    Kawakami,Toshiaki;Blank,Ulrich
  • 通讯作者:
    Blank,Ulrich
Cooperative Regulation of the Mucosal Mast Cell-Specific Protease Genes Mcpt1 and Mcpt2 by GATA and Smad Transcription Factors.
GATA和SMAD转录因子对粘膜肥大细胞特异性蛋白酶MCPT1和MCPT2的合作调节。
  • DOI:
    10.4049/jimmunol.1900094
  • 发表时间:
    2020-03-15
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kasakura K;Nagata K;Miura R;Iida M;Nakaya H;Okada H;Arai T;Arai T;Kawakami Y;Kawakami T;Yashiro T;Nishiyama C
  • 通讯作者:
    Nishiyama C
Novel inhibitors of histamine-releasing factor suppress food allergy in a murine model.
新型组胺释放因子抑制剂可抑制小鼠模型中的食物过敏。
Predictive value of 7S globulin-specific IgE in Japanese macadamia nut allergy patients.
7S 球蛋白特异性 IgE 对日本澳洲坚果过敏患者的预测价值。
  • DOI:
    10.1016/j.jaip.2021.12.039
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yasudo,Hiroki;Ando,Tomoaki;Kitaura,Jiro;Maruyama,Nobuyuki;Narita,Masami;Natsume,Osamu;Uneoka,Kei;Miura,Katsushi;Morita,Yoshinori;Kamei,Anna;Okamoto,Yoko;Shirakawa,Seigo;Kitabayashi,Taeru;Kurihara,Kazuyuki;Nogami,Kazuyoshi;Tak
  • 通讯作者:
    Tak
Histamine-Releasing Factor Is a Novel Alarmin Induced by House Dust Mite Allergen, Cytokines, and Cell Death.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOSHIAKI KAWAKAMI其他文献

TOSHIAKI KAWAKAMI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TOSHIAKI KAWAKAMI', 18)}}的其他基金

Crosstalk between FceRI and MAVS signaling pathways in mast cells
肥大细胞中 FceRI 和 MAVS 信号通路之间的串扰
  • 批准号:
    10040848
  • 财政年份:
    2020
  • 资助金额:
    $ 63.43万
  • 项目类别:
Histamine-Releasing Factor Oligomers in Food Allergy
食物过敏中的组胺释放因子低聚物
  • 批准号:
    10212221
  • 财政年份:
    2019
  • 资助金额:
    $ 63.43万
  • 项目类别:
Interaction of histamine-releasing factor with immunoglobulins in asthma
哮喘中组胺释放因子与免疫球蛋白的相互作用
  • 批准号:
    8766032
  • 财政年份:
    2014
  • 资助金额:
    $ 63.43万
  • 项目类别:
Mast cell Stat5-regulatory pathway in atopic dermatitis
特应性皮炎中肥大细胞 Stat5 调节通路
  • 批准号:
    9042923
  • 财政年份:
    2014
  • 资助金额:
    $ 63.43万
  • 项目类别:
Interaction of histamine-releasing factor with immunoglobulins in asthma
哮喘中组胺释放因子与免疫球蛋白的相互作用
  • 批准号:
    9298705
  • 财政年份:
    2014
  • 资助金额:
    $ 63.43万
  • 项目类别:
Regulation of asthma by Btk and family kinases
Btk 和家族激酶对哮喘的调节
  • 批准号:
    6831364
  • 财政年份:
    2004
  • 资助金额:
    $ 63.43万
  • 项目类别:
Regulation of asthma by Btk and family kinases
Btk 和家族激酶对哮喘的调节
  • 批准号:
    7083557
  • 财政年份:
    2004
  • 资助金额:
    $ 63.43万
  • 项目类别:
Regulation of asthma by Btk and family kinases
Btk 和家族激酶对哮喘的调节
  • 批准号:
    7248798
  • 财政年份:
    2004
  • 资助金额:
    $ 63.43万
  • 项目类别:
Regulation of asthma by Btk and family kinases
Btk 和家族激酶对哮喘的调节
  • 批准号:
    6919293
  • 财政年份:
    2004
  • 资助金额:
    $ 63.43万
  • 项目类别:
Regulation of asthma by Btk and family kinases
Btk 和家族激酶对哮喘的调节
  • 批准号:
    7470157
  • 财政年份:
    2004
  • 资助金额:
    $ 63.43万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了